Functional studies confirmed that BHLHE40 drives tumor cell proliferation, migration, invasion and liver metastasis both in vitro and in vivo. This discovery of a tumor cell-to-CAF axis demonstrates a novel mechanism of metastatic adaptation and positions BHLHE40 and its downstream pathways as a target for therapeutic intervention to prevent metastatic seeding. Here, BHLHE40 is linked to neoplasm.